Dr. Lisa G. Abbott, MD
Endocrinology & Diabetes (Endocrinology, Diabetes & Metabolism Physician)
665 Sierra Rose Dr
Reno, NV 89511
Who else practices at this address →
Washoe County includes primary care (2% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- University of Southern California Keck School of Medicine (1988)
- Years since graduation
- 38
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 454
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1988Medical school: University of Southern California Keck School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Endocrinology, Diabetes & Metabolism Physician primary
NV license 6743
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Renown Regional Medical Center Reno, NV
- Renown South Meadows Medical Center Reno, NV
- Carson Valley Health Gardnerville, NV
- Tahoe Forest Hospital Truckee, CA
- Plumas District Hospital Quincy, CA
Medical groups
- Lisa G Abbott MD A Professional Corporation (2 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 454
- Services billed
- 6,697
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 20-29 minutes | 701 | 299 |
| Established patient office or other outpatient visit, 30-39 minutes | 577 | 225 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 159 | 57 |
| Hemoglobin a1c level | 102 | 69 |
| Ultrasound scan of head and neck soft tissue | 67 | 61 |
| Nerve conduction study of arm or leg movement and/or feeling with review and report | 35 | 35 |
| Complete ultrasound study of arm and leg arteries | 34 | 34 |
| Established patient office or other outpatient visit, 40-54 minutes | 19 | 18 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | 16 | 14 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Synthroid (levothyroxine sodium) Other prescribers in Reno, NV | 299 |
| Levothyroxine Sodium Other prescribers in Reno, NV | 172 |
| Levoxyl (levothyroxine sodium) Other prescribers in Reno, NV | 131 |
| Armour Thyroid (thyroid,pork) Other prescribers in Reno, NV | 66 |
| Liothyronine Sodium Other prescribers in Reno, NV | 34 |
| Hydrocortisone Other prescribers in Reno, NV | 29 |
| Alendronate Sodium Other prescribers in Reno, NV | 26 |
| Atorvastatin Calcium Other prescribers in Reno, NV | 24 |
| Euthyrox (levothyroxine sodium) Other prescribers in Reno, NV | 23 |
| Jardiance (empagliflozin) Other prescribers in Reno, NV | 22 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 30 companies reported 176 payments worth $49,859 in total to this clinician.
| Ascendis Pharma Endocrinology Inc | $45,912 |
|---|---|
| Amgen Inc. | $405 |
| Recordati_rare_diseases_inc. | $385 |
| Xeris Pharmaceuticals, Inc. | $325 |
| Lilly USA, LLC | $292 |
| Neurocrine Biosciences, Inc. | $290 |
| Bayer HealthCare Pharmaceuticals Inc. | $240 |
| Mannkind Corporation | $217 |
| Compensation for services other than consulting (speaking, faculty) | $39,270 |
|---|---|
| Travel and Lodging | $5,646 |
| Food and Beverage | $4,943 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Ascendis Pharma Endocrinology Inc Nov 19, 2025 | Compensation for services other than consulting (speaking, faculty) Yorvipath · Endocrinology | $6,188 |
| Ascendis Pharma Endocrinology Inc Jan 31, 2025 | Compensation for services other than consulting (speaking, faculty) Yorvipath · Endocrinology | $6,188 |
| Ascendis Pharma Endocrinology Inc Mar 12, 2025 | Compensation for services other than consulting (speaking, faculty) Yorvipath · Endocrinology | $3,808 |
| Ascendis Pharma Endocrinology Inc May 23, 2025 | Compensation for services other than consulting (speaking, faculty) | $3,808 |
| Ascendis Pharma Endocrinology Inc Feb 26, 2025 | Compensation for services other than consulting (speaking, faculty) Yorvipath · Endocrinology | $2,856 |
| Ascendis Pharma Endocrinology Inc Jun 4, 2025 | Compensation for services other than consulting (speaking, faculty) Yorvipath · Endocrinology | $2,618 |
| Ascendis Pharma Endocrinology Inc Nov 26, 2025 | Compensation for services other than consulting (speaking, faculty) | $2,142 |
| Ascendis Pharma Endocrinology Inc Mar 7, 2025 | Compensation for services other than consulting (speaking, faculty) Yorvipath · Endocrinology | $2,142 |
| Ascendis Pharma Endocrinology Inc Feb 26, 2025 | Compensation for services other than consulting (speaking, faculty) Yorvipath · Endocrinology | $1,785 |
| Ascendis Pharma Endocrinology Inc Feb 19, 2025 | Compensation for services other than consulting (speaking, faculty) Yorvipath · Endocrinology | $1,190 |
All 46 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Ascendis Pharma Endocrinology Inc Dec 5, 2025 | Travel and Lodging Yorvipath · Endocrinology · travel to Chicago, IL | $46.40 |
| Ascendis Pharma Endocrinology Inc Dec 5, 2025 | Travel and Lodging Yorvipath · Endocrinology · travel to Chicago, IL | $13.72 |
| Ascendis Pharma Endocrinology Inc Nov 26, 2025 | Compensation for services other than consulting (speaking, faculty) | $2,142 |
| Ascendis Pharma Endocrinology Inc Nov 19, 2025 | Compensation for services other than consulting (speaking, faculty) Yorvipath · Endocrinology | $6,188 |
| Ascendis Pharma Endocrinology Inc Jun 23, 2025 | Travel and Lodging Yorvipath · Endocrinology · travel to Anchorage, AK | $91.94 |
| Ascendis Pharma Endocrinology Inc Jun 23, 2025 | Travel and Lodging Yorvipath · Endocrinology · travel to Anchorage, AK | $33.90 |
| Ascendis Pharma Endocrinology Inc Jun 23, 2025 | Travel and Lodging Yorvipath · Endocrinology · travel to Anchorage, AK | $11.50 |
| Ascendis Pharma Endocrinology Inc Jun 18, 2025 | Travel and Lodging travel to PORTLAND, OR | $151 |
| Ascendis Pharma Endocrinology Inc Jun 18, 2025 | Travel and Lodging travel to PORTLAND, OR | $53.04 |
| Ascendis Pharma Endocrinology Inc Jun 18, 2025 | Travel and Lodging travel to PORTLAND, OR | $34.00 |
| Ascendis Pharma Endocrinology Inc Jun 4, 2025 | Compensation for services other than consulting (speaking, faculty) Yorvipath · Endocrinology | $2,618 |
| Ascendis Pharma Endocrinology Inc May 24, 2025 | Travel and Lodging travel to PORTLAND, OR | $537 |
| Ascendis Pharma Endocrinology Inc May 24, 2025 | Travel and Lodging Yorvipath · Endocrinology · travel to Anchorage, AK | $537 |
| Ascendis Pharma Endocrinology Inc May 23, 2025 | Compensation for services other than consulting (speaking, faculty) | $3,808 |
| Ascendis Pharma Endocrinology Inc May 23, 2025 | Travel and Lodging travel to PORTLAND, OR | $180 |
| Ascendis Pharma Endocrinology Inc May 23, 2025 | Travel and Lodging Yorvipath · Endocrinology · travel to Anchorage, AK | $180 |
| Ascendis Pharma Endocrinology Inc May 10, 2025 | Travel and Lodging travel to PORTLAND, OR | $260 |
| Ascendis Pharma Endocrinology Inc May 10, 2025 | Travel and Lodging Yorvipath · Endocrinology · travel to Anchorage, AK | $260 |
| Ascendis Pharma Endocrinology Inc May 10, 2025 | Travel and Lodging travel to PORTLAND, OR | $209 |
| Ascendis Pharma Endocrinology Inc May 10, 2025 | Travel and Lodging Yorvipath · Endocrinology · travel to Anchorage, AK | $209 |
| Ascendis Pharma Endocrinology Inc May 10, 2025 | Travel and Lodging travel to PORTLAND, OR | $119 |
| Ascendis Pharma Endocrinology Inc May 10, 2025 | Travel and Lodging Yorvipath · Endocrinology · travel to Anchorage, AK | $119 |
| Ascendis Pharma Endocrinology Inc May 7, 2025 | Compensation for services other than consulting (speaking, faculty) Yorvipath · Endocrinology | $1,190 |
| Ascendis Pharma Endocrinology Inc Apr 9, 2025 | Compensation for services other than consulting (speaking, faculty) Yorvipath · Endocrinology | $1,190 |
| Ascendis Pharma Endocrinology Inc Apr 9, 2025 | Compensation for services other than consulting (speaking, faculty) Yorvipath · Endocrinology | $1,190 |
| Ascendis Pharma Endocrinology Inc Apr 4, 2025 | Compensation for services other than consulting (speaking, faculty) Yorvipath · Endocrinology | $595 |
| Ascendis Pharma Endocrinology Inc Mar 19, 2025 | Compensation for services other than consulting (speaking, faculty) | $1,190 |
| Ascendis Pharma Endocrinology Inc Mar 12, 2025 | Compensation for services other than consulting (speaking, faculty) Yorvipath · Endocrinology | $3,808 |
| Ascendis Pharma Endocrinology Inc Mar 8, 2025 | Travel and Lodging Yorvipath · Endocrinology · travel to West Hollywood, CA | $998 |
| Ascendis Pharma Endocrinology Inc Mar 7, 2025 | Compensation for services other than consulting (speaking, faculty) Yorvipath · Endocrinology | $2,142 |
| Ascendis Pharma Endocrinology Inc Feb 28, 2025 | Compensation for services other than consulting (speaking, faculty) Yorvipath · Endocrinology | $1,190 |
| Ascendis Pharma Endocrinology Inc Feb 28, 2025 | Travel and Lodging Yorvipath · Endocrinology · travel to San Ramon, CA | $318 |
| Ascendis Pharma Endocrinology Inc Feb 28, 2025 | Travel and Lodging Yorvipath · Endocrinology · travel to San Ramon, CA | $54.00 |
| Ascendis Pharma Endocrinology Inc Feb 26, 2025 | Compensation for services other than consulting (speaking, faculty) Yorvipath · Endocrinology | $2,856 |
| Ascendis Pharma Endocrinology Inc Feb 26, 2025 | Compensation for services other than consulting (speaking, faculty) Yorvipath · Endocrinology | $1,785 |
| Ascendis Pharma Endocrinology Inc Feb 22, 2025 | Travel and Lodging Yorvipath · Endocrinology · travel to Fremont, CA | $317 |
| Ascendis Pharma Endocrinology Inc Feb 22, 2025 | Travel and Lodging Yorvipath · Endocrinology · travel to West Hollywood, CA | $20.99 |
| Ascendis Pharma Endocrinology Inc Feb 22, 2025 | Travel and Lodging Yorvipath · Endocrinology · travel to West Hollywood, CA | $14.99 |
| Ascendis Pharma Endocrinology Inc Feb 21, 2025 | Travel and Lodging Yorvipath · Endocrinology · travel to West Hollywood, CA | $216 |
| Ascendis Pharma Endocrinology Inc Feb 19, 2025 | Compensation for services other than consulting (speaking, faculty) Yorvipath · Endocrinology | $1,190 |
| Ascendis Pharma Endocrinology Inc Feb 13, 2025 | Travel and Lodging Yorvipath · Endocrinology · travel to West Hollywood, CA | $93.48 |
| Ascendis Pharma Endocrinology Inc Feb 11, 2025 | Travel and Lodging Yorvipath · Endocrinology · travel to Fremont, CA | $263 |
| Ascendis Pharma Endocrinology Inc Feb 11, 2025 | Travel and Lodging Yorvipath · Endocrinology · travel to San Ramon, CA | $263 |
| Ascendis Pharma Endocrinology Inc Feb 5, 2025 | Travel and Lodging Yorvipath · Endocrinology · travel to Dallas, TX | $32.00 |
| Ascendis Pharma Endocrinology Inc Feb 5, 2025 | Travel and Lodging Yorvipath · Endocrinology · travel to Dallas, TX | $9.52 |
| Ascendis Pharma Endocrinology Inc Jan 31, 2025 | Compensation for services other than consulting (speaking, faculty) Yorvipath · Endocrinology | $6,188 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 9 industry-funded studies in 2025, from 6 companies. The companies reported $365,891 in research payments for these studies, mostly to the institutions running them.
- A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
AbbVie Inc. · Active, not recruiting · NCT06345339 - A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk
Eli Lilly and Company · Completed · NCT05803421 - PaTHway TRIAL
Ascendis Pharma Endocrinology Inc - A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
AbbVie Inc. - Eneboparatide - Calypso study which is a pivotal phase 3 study investigational therapeutic peptide with a novel mechanism of action for hypoparathyroidism
Alexion Pharmaceuticals, Inc. - Expanded Access Program of Palopegteriparatide in Patients With Hypoparathyroidism
Ascendis Pharma Endocrinology Inc · Approved for marketing · NCT05654701 - M21-341 - A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
AbbVie Inc. - A Registry for Participants With Chronic Hypoparathyroidism
Takeda Pharmaceuticals U.S.A., Inc. · Completed · NCT01922440 - Study name not reported
Novo Nordisk As
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.